P

Pulse Biosciences
D

PLSE

19.480
USD
-0.56
(-2.79%)
مغلق
حجم التداول
2,453
الربح لكل سهم
-1
العائد الربحي
-
P/E
-24
حجم السوق
1,198,344,868
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BCLI
    -0.08000
    (-4.42%)
    1.73000 USD
    C
    CLSD
    -0.03000
    (-2.94%)
    0.99000 USD
    D
    DOC
    -0.010
    (-0.05%)
    19.760 USD
    E
    ENTG
    -3.260
    (-3.04%)
    104.010 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    R
    RGEN
    -3.710
    (-2.28%)
    158.950 USD
    S
    SEER
    -0.03000
    (-1.31%)
    2.26000 USD
    T
    TECH
    -0.510
    (-0.78%)
    64.920 USD
    V
    VCYT
    -1.820
    (-4.43%)
    39.230 USD
    المزيد
الأخبار
المقالات

العنوان: Pulse Biosciences

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.